Ownership history in Qube Research & Technologies Ltd · 10 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in LIFECORE BIOMEDICAL INC (LFCR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 14,133 | -3,533 | -20.0% | 0.00% | $104K | $7.36 |
| 2025 Q2 | REDUCED | 17,666 | -37,741 | -68.1% | 0.00% | $143K | $8.12 |
| 2025 Q1 | REDUCED | 55,407 | -19,325 | -25.9% | 0.00% | $390K | $7.04 |
| 2024 Q4 | REDUCED | 74,732 | -19,644 | -20.8% | 0.00% | $555K | $7.43 |
| 2024 Q3 | ADDED | 94,376 | +12,904 | +15.8% | 0.00% | $465K | $4.93 |
| 2024 Q2 | REDUCED | 81,472 | -61,807 | -43.1% | 0.00% | $418K | $5.13 |
| 2024 Q1 | REDUCED | 143,279 | -4,147 | -2.8% | 0.00% | $761K | $5.31 |
| 2023 Q4 | ADDED | 147,426 | +120,095 | +439.4% | 0.00% | $913K | $6.19 |
| 2023 Q3 | REDUCED | 27,331 | -580 | -2.1% | 0.00% | $206K | $7.55 |
| 2023 Q2 | INITIATED | 27,911 | — | — | 0.00% | $270K | $9.67 |
As of 2025 Q4 — sorted by position size